Novo Nordisk says it is suing Eli Lilly, accusing it of false advertising
Novo Nordisk sues Eli Lilly for false advertising, alleging its rival's weight-loss drug ads use misleading comparisons to inflate efficacy claims.
Subscribing is the best way to get our best stories immediately.